2020
DOI: 10.1002/pd.5824
|View full text |Cite
|
Sign up to set email alerts
|

Reproductive male partner testing when the female is identified to be a genetic disease carrier

Abstract: Objective To quantify carrier testing uptake rates for male partners of women found to be a carrier(s) for autosomal recessive conditions and to understand reasons for declining testing (uptake rate). Methods A retrospective chart review of 513 female patients seen at Rutgers‐Robert Wood Johnson Medical School found to be carriers through expanded carrier screening (ECS) panels. The aims of this study were to determine how often their male partner chose testing, reasons for declining and the type of methodolog… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
15
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 20 publications
2
15
0
Order By: Relevance
“…protocol for arranging posttest counseling appointments, drawing the partner's blood on the day of the follow-up visit, and offering free or reduced-cost testing in many cases. 12 In our study, high compliance in the tandem and tandem reflex groups translated into a higher percentage of identified ARCs compared to the sequential group, a result additionally demonstrated by modeling data.…”
Section: Discussionsupporting
confidence: 74%
See 2 more Smart Citations
“…protocol for arranging posttest counseling appointments, drawing the partner's blood on the day of the follow-up visit, and offering free or reduced-cost testing in many cases. 12 In our study, high compliance in the tandem and tandem reflex groups translated into a higher percentage of identified ARCs compared to the sequential group, a result additionally demonstrated by modeling data.…”
Section: Discussionsupporting
confidence: 74%
“…7 Male partners have also reported the belief that results would not impact pregnancy management, not wanting to know their carrier status, and concern about the cost and insurance coverage of screening. 12,13 A recent study's comparatively high frequency of compliance (77%) was attributed to the center's ARJUNAN ET AL.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[53][54][55][56]80,89 Time points of measurement were also variable. A single time point was assessed by most studies (n = 41, 85%) and included audit data from databases between 1-30 years since screening (n = 34, 83%), 29,30,[32][33][34][35][36]38,40,42,[47][48][49]52,57,60,61,[63][64][65][67][68][69]73,74,78,81,[83][84][85][86][87][88]90,91,93 patient-reported outcomes at pre-test counselling after the decision to accept or decline was made (n = 3, 7%), 75,76,82 after maternal results but before partner results (n = 1, 2%), 39 and after results between 1-2 years since screening (n = 3, 7%). 46,51,…”
Section: Measurement Methodsmentioning
confidence: 99%
“…The traditional carrier screen base scenario was developed from the standard workflow typically carried out in obstetric clinics in the US. We did not account for the concurrent screening model where the mother and father of the pregnancy are tested simultaneously, as this model is not commonly used in obstetric clinics [9][10][11][12] . The carrier screen with reflex sgNIPT workflow (reflex sgNIPT scenario) was developed from the standard carrier screening workflow in obstetric clinics.…”
Section: Decision-analytic Modelmentioning
confidence: 99%